NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
Lingfeng WanTao LiuZhipeng HongYou PanSteven T SizemoreJunran ZhangZhefu MaPublished in: Breast cancer research : BCR (2019)
NEDD4 expression is elevated in BC and is associated with BC growth. NEDD4 correlated with clinicopathological parameters and predicts a poor prognosis. Thus, NEDD4 is a potential biomarker of poor prognosis and a potential therapeutic target for BC treatment.